Literature DB >> 21705359

Nutrition in cardiovascular disease: salt in hypertension and heart failure.

Feng J He1, Michel Burnier, Graham A Macgregor.   

Abstract

There is much evidence for a causal relationship between salt intake and blood pressure (BP). The current salt intake in many countries is between 9 and 12 g/day. A reduction in salt intake to the recommended level of 5-6 g/day lowers BP in both hypertensive and normotensive individuals. A further reduction to 3-4 g/day has a much greater effect. Prospective studies and outcome trials have demonstrated that a lower salt intake is associated with a decreased risk of cardiovascular disease. Increasing evidence also suggests that a high salt intake is directly related to left ventricular hypertrophy (LVH) independent of BP. Both raised BP and LVH are important risk factors for heart failure. It is therefore possible that a lower salt intake could prevent the development of heart failure. In patients who already have heart failure, a high salt intake aggravates the retention of salt and water, thereby exacerbating heart failure symptoms and progression of the disease. A lower salt intake plays an important role in the management of heart failure. Despite this, currently there is no clear evidence on how far salt intake should be reduced in heart failure. Our personal view is that these patients should reduce their salt intake to <5 g/day, i.e. the maximum intake recommended by the World Health Organisation for all adults. If salt intake is successfully reduced, there may well be a need for a reduction in diuretic dosage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705359     DOI: 10.1093/eurheartj/ehr194

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

Review 1.  The role of ENaC in vascular endothelium.

Authors:  Kristina Kusche-Vihrog; Pia Jeggle; Hans Oberleithner
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

2.  Salt, hypertension, vascular stiffness and diastolic dysfunction, what comes first?

Authors:  M Bursztyn
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

3.  Prediction of 24-hour sodium excretion from spot urine samples in South African adults: a comparison of four equations.

Authors:  Karen Charlton; Lisa J Ware; Glory Chidumwa; Marike Cockeran; Aletta E Schutte; Nirmala Naidoo; Paul Kowal
Journal:  J Hum Hypertens       Date:  2019-05-10       Impact factor: 3.012

4.  Sodium restriction in heart failure: benefit or harm?

Authors:  Matthew C Konerman; Scott L Hummel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

Review 5.  New approaches to modulating idiopathic pulmonary fibrosis.

Authors:  Richard H Gomer
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

6.  Effect of Various Sodium Chloride Mass Fractions on Wheat and Rye Bread Using Different Dough Preparation Techniques.

Authors:  Marta Ambrosewicz-Walacik; Małgorzata Tańska; Daniela Rotkiewicz; Andrzej Piętak
Journal:  Food Technol Biotechnol       Date:  2016-06       Impact factor: 3.918

7.  Dietary Sodium Intake is Predicted by Antihypertensive Medication Regimen in Patients With Heart Failure.

Authors:  Jennifer L Smith; Terry A Lennie; Misook L Chung; Gia Mudd-Martin
Journal:  J Cardiovasc Nurs       Date:  2019 Jul/Aug       Impact factor: 2.083

Review 8.  Vitamin C supplementation for the primary prevention of cardiovascular disease.

Authors:  Lena Al-Khudairy; Nadine Flowers; Rebecca Wheelhouse; Obadah Ghannam; Louise Hartley; Saverio Stranges; Karen Rees
Journal:  Cochrane Database Syst Rev       Date:  2017-03-16

9.  Dietary NaCl affects bleomycin-induced lung fibrosis in mice.

Authors:  Wensheng Chen; Darrell Pilling; Richard H Gomer
Journal:  Exp Lung Res       Date:  2017-12-08       Impact factor: 2.459

Review 10.  Green and black tea for the primary prevention of cardiovascular disease.

Authors:  Louise Hartley; Nadine Flowers; Jennifer Holmes; Aileen Clarke; Saverio Stranges; Lee Hooper; Karen Rees
Journal:  Cochrane Database Syst Rev       Date:  2013-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.